Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

This study is currently recruiting participants.

Verified April 2013 by United Therapeutics

Sponsor:

Information provided by (Responsible Party):

United Therapeutics

ClinicalTrials.gov Identifier:

NCT01795950

First received: February 12, 2013

Last updated: April 22, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2015
Estimated Primary Completion Date:	September 2015 (Final data collection date for primary outcome measure)